Human teratogens update 2011: Can we ensure safety during pregnancy?
- 13 February 2012
- journal article
- review article
- Published by Wiley in Birth Defects Research Part A: Clinical and Molecular Teratology
- Vol. 94 (3), 123-128
- https://doi.org/10.1002/bdra.22887
Abstract
Anniversaries of the identification of three human teratogens (i.e., rubella virus in 1941, thalidomide in 1961, and diethylstilbestrol in 1971) occurred in 2011. These experiences highlight the critical role that scientists with an interest in teratology play in the identification of teratogenic exposures as the basis for developing strategies for prevention of those exposures and the adverse outcomes associated with them. However, an equally important responsibility for teratologists is to evaluate whether medications and vaccines are safe for use during pregnancy so informed decisions about disease treatment and prevention during pregnancy can be made. Several recent studies have examined the safety of medications during pregnancy, including antiviral medications used to treat herpes simplex and zoster, proton pump inhibitors used to treat gastroesophageal reflux, and newer‐generation antiepileptic medications used to treat seizures and other conditions. Despite the large numbers of pregnant women included in these studies and the relatively reassuring results, the question of whether these medications are teratogens remains. In addition, certain vaccines are recommended during pregnancy to prevent infections in mothers and infants, but clinical trials to test these vaccines typically exclude pregnant women; thus, evaluation of their safety depends on observational studies. For pregnant women to receive optimal care, we need to define the data needed to determine whether a medication or vaccine is “safe” for use during pregnancy. In the absence of adequate, well‐controlled data, it will often be necessary to weigh the benefits of medications or vaccines with potential risks to the embryo or fetus. Birth Defects Research (Part A), 2012. © Published 2012 Wiley Periodicals, Inc.Keywords
This publication has 59 references indexed in Scilit:
- Evolving knowledge of the teratogenicity of medications in human pregnancyAmerican Journal Of Medical Genetics Part C-Seminars In Medical Genetics, 2011
- Teratogenic exposuresAmerican Journal Of Medical Genetics Part C-Seminars In Medical Genetics, 2011
- The art and science of teratogen risk communicationAmerican Journal Of Medical Genetics Part C-Seminars In Medical Genetics, 2011
- Maternal immunization with tetanus–diphtheria–pertussis vaccine: effect on maternal and neonatal serum antibody levelsAmerican Journal of Obstetrics and Gynecology, 2011
- The safety of immunizing with tetanus–diphtheria–acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreakVaccine, 2010
- Prenatal Exposure to Acetaminophen and Asthma in ChildrenObstetrics & Gynecology, 2009
- Prenatal acetaminophen exposure and risk of wheeze at age 5 years in an urban low-income cohortThorax, 2009
- Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding womenCMAJ : Canadian Medical Association Journal, 2009
- Prenatal exposure to acetaminophen and respiratory symptoms in the first year of lifeAnnals of Allergy, Asthma & Immunology, 2008
- Pandemic Influenza and Pregnant WomenEmerging Infectious Diseases, 2008